today announced acceptance of an oral presentation at the upcoming American College of Rheumatology (ACR) Convergence 2024 ...
News Medical on MSN1d
Lupus Research Alliance announces 33 studies to be presented at ACR Convergence 2024The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...
The Lupus Research Alliance (LRA), the largest private funder of lupus research worldwide, today announced that a total of 33 studies, funded by the organization or supported by its clinical research ...
CAMBRIDGE, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: CGEM), a biopharmaceutical company focused on developing modality-agnostic targeted therapies, today announced the upcoming presentation ...
at American College of Rheumatology (ACR) Convergence 2024, taking place in Washington, D.C. from November 14-19, 2024. “These preclinical data show that CLN-978 is a highly potent T cell ...
LEVI-04 is a proprietary p75 neurotrophin receptor fusion protein (p75NTR-Fc) that provides analgesia via inhibition of NT-3 activity and returns neurotrophin homeostasis by supplementing the ...
Cullinan Therapeutics (CGEM) announced the upcoming presentation of preclinical data for CLN-978, a novel CD19xCD3 bispecific T cell engager, ...
ACR Convergence 2024, being held from 14 November to 19 November, 2024 in Washington, DC. LEVI-04 is a proprietary p75 neurotrophin receptor fusion protein (p75NTR-Fc) that provides analgesia via ...
mouse model at ACR Convergence 2024, held November 14-19, in Washington DC. In addition, Dr. Kulveer Mankia, investigator at the Leeds Institute of Rheumatic and Musculoskeletal Medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback